|
|
 |
|
Viewing report
|
|
|
|
Generics Series: Generics Trends in the Seven Major Markets and Beyond
Datamonitor, Dec 2008, Pages: 107
Introduction
Based on generics use, the seven major markets may be divided into mature (the US, Germany and the UK) and immature (France, Italy, Spain and Japan) markets, both of which present different challenges, making the fast-growing, high-value emerging markets a tantalizing prospect. In addition to market expansion, acquisition and closer innovator ties represent key strategies for industry growth.
Scope
- An overview of key events which have impacted on the generics industry in the seven major markets.
- An insight into the strategic trends employed by the industry to sustain growth in an increasingly competitive environment.
- An introduction to the emerging markets, as the next frontier for industry growth.
- An outline of how recent M&A activity has altered the generics industry landscape.
Highlights
The global generics market is growing, however it will be the immature and emerging generics markets which will increasingly drive growth, as competitive pressures in the more mature markets intensify, and make sustaining revenue growth more difficult here.
Consolidation continues to be a crucial strategy for generics industry growth, with recent M&A activity having reinforced the position of some companies, whilst bolstering the ranking of others. The magnitude of acquisitions has also increased, and given current economic conditions, such high price-tags may not be sustainable.
The increasingly close relationship between generics and branded companiesfeared by regulators to delay generics market entry in some caseshas reached an extreme in the recent acquisitions of generics companies by innovators, a response to the pressures the latter are under.
Reasons to Purchase
- Identify the issues are impacting on the generics industry in the seven major markets.
- Understand why the emerging markets are increasingly a target for generics companies.
- Identify the key strategic trends for the generics industry in the future.
Customers who bought this item also bought
Global Generics Industry Report
Generics: Global Industry Guide
Generics Series: Key trends and events in the 7 major markets
Mylan: PharmaVitae Generics Profile
New Dynamics and Challenges in the Generics Market 2007
Generics Series: Authorized Generics Analysis
Global Generics Industry Report
Pharmavitae Generics - Teva
Generics in France
Generics Growth Strategies: Cost Containment and M&A Shape the Global Generics Industry
Indian Generics, 2008-2012: The Growing Threat to Westernised Markets
Generic Series: An Introduction To The Canadian Generics Market - Key Trends And Leading Companies Shaping The Market
|
|
|
|
